RBC Capital Maintains Outperform on Addus HomeCare, Lowers Price Target to $110
RBC Capital analyst Ben Hendrix maintains Addus HomeCare (NASDAQ:ADUS) with a Outperform and lowers the price target from $111 to $110.
Recap: Addus HomeCare Q2 Earnings
Addus HomeCare (NASDAQ:ADUS) reported its Q2 earnings results on Monday, August 1, 2022 at 04:05 PM.
Here's what investors need to know about the announcement.
Earnings Scheduled For August 1, 2022
Companies Reporting Before The Bell
• Bon Natural Life (NASDAQ:BON) is projected to report earnings for its first quarter.